Literature DB >> 10389229

T cell receptor usage in autoimmune disease.

P Moss1, J Bell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389229     DOI: 10.1007/bf00815175

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  108 in total

1.  Molecular analysis of the T-cell receptor beta-chain repertoire in early rheumatoid arthritis: heterogeneous TCRBV gene usage with shared amino acid profiles in CDR3 regions of T lymphocytes in multiple synovial tissue needle biopsies from the same joint.

Authors:  L Struyk; G E Hawes; H M Mikkers; P P Tak; F C Breedveld; P J van den Elsen
Journal:  Eur J Clin Invest       Date:  1996-12       Impact factor: 4.686

2.  Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.

Authors:  F De Keyser; D Elewaut; J P Overmeer-Graus; P Van den Broek; A W Rijnders; E M Veys
Journal:  J Rheumatol       Date:  1997-09       Impact factor: 4.666

3.  Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid.

Authors:  K Usuku; N Joshi; C J Hatem; M A Wong; M C Stein; S L Hauser
Journal:  J Neurosci Res       Date:  1996-09-15       Impact factor: 4.164

4.  Human T-cell response to myelin basic protein peptide (83-99): extensive heterogeneity in antigen recognition, function, and phenotype.

Authors:  B Hemmer; M Vergelli; L Tranquill; P Conlon; N Ling; H F McFarland; R Martin
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

5.  Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis.

Authors:  Y C Zang; M Kozovska; I Aebischer; S Li; S Boehme; P Crowe; V M Rivera; J Z Zhang
Journal:  Int Immunol       Date:  1998-07       Impact factor: 4.823

Review 6.  The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor.

Authors:  U Utz; H F McFarland
Journal:  J Neuropathol Exp Neurol       Date:  1994-07       Impact factor: 3.685

7.  T-cell receptor V-gene usage in synovial fluid and synovial tissue from RA patients.

Authors:  S Gudmundsson; J Rönnelid; A Karlsson-Parra; J Lysholm; B Gudbjörnsson; B Widenfalk; C H Janson; L Klareskog
Journal:  Scand J Immunol       Date:  1992-11       Impact factor: 3.487

8.  Limited heterogeneity of rearranged T cell receptor V alpha and V beta transcripts in synovial fluid T cells in early stages of rheumatoid arthritis.

Authors:  D C Fischer; B Opalka; A Hoffmann; W Mayr; H D Haubeck
Journal:  Arthritis Rheum       Date:  1996-03

9.  T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.

Authors:  L W Moreland; E E Morgan; T C Adamson; Z Fronek; L H Calabrese; J M Cash; J A Markenson; A K Matsumoto; J Bathon; E L Matteson; K M Uramoto; C M Weyand; W J Koopman; L W Heck; V Strand; J P Diveley; D J Carlo; C J Nardo; S P Richieri; S W Brostoff
Journal:  Arthritis Rheum       Date:  1998-11

10.  Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis.

Authors:  K Selmaj; C F Brosnan; C S Raine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

View more
  1 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.